A newly developed AI tool can dramatically speed up the search for the genetic causes of rare diseases, a process that often ...
Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes ...
Record full-year total revenue and AVISE ® CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume growth CARLSBAD, Calif., March 10, 2026 (GLOBE ...
Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, ...
NEWARK, DELAWARE / ACCESS Newswire / February 26, 2026 / The global autoimmune disease testing market is witnessing steady expansion as healthcare systems intensify focus on early diagnosis and ...
The MarketWatch News Department was not involved in the creation of this content. CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune ...
“I am pleased to report the completion of another strong year for Exagen in which we’ve continued to make substantial progress in building a great company; a testament to continued execution across ...
VIRGINIA BEACH, Va. (WAVY) — At just 22 years old, Carri Game was focused on living a normal life, until a routine doctor’s visit in early September changed everything. Game went to the doctor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results